title: Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
authors.forename: N A
authors.initials: NA
authors.lastname: Chaudhry
authors.forename: H
authors.initials: H
authors.lastname: Tabandeh
authors.forename: P J
authors.initials: PJ
authors.lastname: Rosenfeld
authors.forename: D
authors.initials: D
authors.lastname: Miller
authors.forename: J
authors.initials: J
authors.lastname: Davis
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000209:etiology; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012163:Retinal Detachment / Q000601:surgery; D012591:Scleral Buckling / Q000009:adverse effects*; D014031:Tobramycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D014031:Tobramycin